Form EFFECT Edesa Biotech, Inc.
- Wall St posts third straight quarterly loss as inflation weighs, recession looms
- Intel's Autonomous Unit Mobileye Files U.S. IPO, Defying Weak Market Conditions
- Nike (NKE) Drops 9% as Inventory Surges 44%, Analysts See Attractive Valuation
- Hollywood Super Agent Attempts to Open Door for Twitter-Musk Settlement - Bloomberg
- Dollar up on euro as quarter ends, commodity led currencies sink
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||August 12, 2022 5:00 P.M.|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Edesa Biotech (EDSA) Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study
- XPeng Announces Vehicle Delivery Results for September and Third Quarter 2022; G9 Flagship SUV deliveries started in September
- A Sunrise Date with Youth in China
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!